Cent Eur J Public Health 2017, 25(3):240-244

Inverse Relationship Between Adherenceto the Mediterranean Diet and Serum Cystatin C Levels

Natalia G. Vallianou1, Ekavi Georgousopoulou2, Angelos A. Evangelopoulos1, Vassiliki Bountziouka2, Maria S. Bonou1, Evangelos D. Vogiatzakis1, Petros C. Avgerinos1, John Barbetseas1, Demosthenes B. Panagiotakos2
1 Evangelismos General Hospital, Athens, Greece
2 Department of Nutrition and Dietetics, Harokopio University of Athens, Athens, Greece

Objective: The aim of the present study was to examine serum cystatin C levels in association with the Mediterranean diet in a healthy Greek population.

Methods: Cystatin C together with basic clinical chemistry tests was measured in a total of 490 adults (46 ± 16 years, 40% of males), who underwent an annual health check. Demographic, anthropometric and lifestyle characteristics were recorded, while adherence to the Mediterranean diet was evaluated through the MedDietScore (0-55).

Results: The mean level of serum cystatin C was 0.84 mg/L, while men had increased serum cystatin C levels compared to women (0.86 mg/L vs. 0.83 mg/L, respectively, 0.017). After adjusting for age, gender, body mass index, smoking status, hypertension, diabetes, hypercholesterolemia, estimated glomerular filtration rate (eGFR), albumin and ferritin levels, each unit increase in MedDietScore led to 0.002 mg/dL drop off in cystatin C serum levels.

Conclusions: We have demonstrated an inverse relationship between the MedDietScore and serum cystatin C levels. Our finding that increases in MedDietScore are associated with decreases in serum cystatin C levels could imply that adherence to the Mediterranean diet may reduce the cardiovascular risk, as assessed by cystatin C, a prognostic marker of the cardiometabolic risk. This notion could have a great impact on public health.

Keywords: cystatin C, MedDietScore, Mediterranean diet, cardiovascular risk

Received: March 1, 2016; Revised: January 2, 2017; Published: October 10, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vallianou NG, Georgousopoulou E, Evangelopoulos AA, Bountziouka V, Bonou MS, Vogiatzakis ED, et al.. Inverse Relationship Between Adherenceto the Mediterranean Diet and Serum Cystatin C Levels. Cent Eur J Public Health. 2017;25(3):240-244. PubMed PMID: 29022685.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Grubb A, Löfberg H. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci U S A. 1982 May;79(9):3024-7. Go to original source... Go to PubMed...
    2. Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun. 1984 Apr 30;120(2):631-6. Go to original source... Go to PubMed...
    3. Barrett AJ, Fritz H, Grubb A, Isemura S, Järvinen M, Katunuma N, et al. Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J. 1986 May 15;236(1):312. Go to original source... Go to PubMed...
    4. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest. 1985 Apr;45(2):97-101. Go to original source... Go to PubMed...
    5. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function - a review. Clin Chem Lab Med. 1999 Apr;37(4):389-95. Go to original source... Go to PubMed...
    6. Abrahamson M, Olafsson I, Palsdottir A, Ulvsbäck M, Lundwall A, Jensson O, et al. Structure and expression of the human cystatin C gene. Biochem J. 1990 Jun 1;268(2):287-94. Go to original source... Go to PubMed...
    7. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006 Aug 15;145(4):237-46. Go to original source...
    8. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005 May 19;352(20):2049-60. Go to original source... Go to PubMed...
    9. Leung-Tack J, Tavera C, Gensac MC, Martinez J, Colle A. Modulation of phagocytosis-associated respiratory burst by human cystatin C: role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg. Exp Cell Res. 1990 May;188(1):16-22. Go to original source...
    10. Bountziouka V, Bathrellou E, Giotopoulou A, Katsagoni C, Bonou M, Vallianou N, et al. Development, repeatability and validity regarding energy and macronutrient intake of a semi-quantitative food frequency questionnaire: methodological considerations. Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):659-67. doi: 10.1016/j. numecd.2010.10.015. Go to original source... Go to PubMed...
    11. Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med. 2007 Apr;44(4):335-40. Go to original source... Go to PubMed...
    12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62-9. Go to original source... Go to PubMed...
    13. Abrahamson M, Dalbøge H, Olafsson I, Carlsen S, Grubb A. Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett. 1988 Aug 15;236(1):14-8. Go to original source... Go to PubMed...
    14. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004 Apr;65(4):1416-21. Go to original source... Go to PubMed...
    15. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009 Mar;75(6):652-60. Go to original source... Go to PubMed...
    16. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1992;38 Suppl 1:S20-7. Go to PubMed...
    17. Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000 Jul;36(1):29-34. Go to original source... Go to PubMed...
    18. Muntner P, Mann D, Winston J, Bansilal S, Farkouh ME. Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. Am J Cardiol. 2008 Jul 1;102(1):54-7. Go to original source... Go to PubMed...
    19. Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Clin Chem. 2009 Nov;55(11):1932-43. Go to original source... Go to PubMed...
    20. Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, et al. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005 Dec;118(12):1416. Go to original source... Go to PubMed...
    21. Evangelopoulos AA, Vallianou NG, Bountziouka V, Katsagoni C, Bathrellou E, Vogiatzakis ED, et al. Association between serum cystatin C, monocytes and other inflammatory markers. Intern Med J. 2012 May;42(5):517-22. Go to original source... Go to PubMed...
    22. Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke. 2004 Jul;35(7):1619-24. Go to original source... Go to PubMed...
    23. Huang ZS, Wang CH, Yip PK, Yang CY, Lee TK. In hypercholesterolemia, lower peripheral monocyte count is unique among the major predictors of atherosclerosis. Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):256-61. Go to original source... Go to PubMed...
    24. Rodgers KJ, Watkins DJ, Miller AL, Chan PY, Karanam S, Brissette WH, et al. Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):851-6. Go to original source... Go to PubMed...
    25. Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, Djordjevic BS, et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 1986 Dec;124(6):903-15. Go to original source...
    26. Forman D, Bulwer BE. Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle. Curr Treat Options Cardiovasc Med. 2006 Feb;8(1):47-57. Go to original source... Go to PubMed...
    27. Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI, et al.; PREDIMED Study Investigators. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006 Jul 4;145(1):1-11. Go to original source...
    28. Giugliano D, Esposito K. Mediterranean diet and cardiovascular health. Ann N Y Acad Sci. 2005 Nov;1056:253-60. Go to original source... Go to PubMed...

    Return to the content